CFH and thrombotic microangiopathy: The presence of this microarray on chromosome 1 may be associated with the production of antibodies to factor H complement (CFH) and activation of the complement system through an alternative pathway with endothelial damage and, consequently, the development of thrombotic microangiopathy.